|
US2770569A
(en)
|
1952-08-01 |
1956-11-13 |
Hoffmann La Roche |
Analgesic compositions
|
|
US3173877A
(en)
*
|
1957-09-09 |
1965-03-16 |
Wyandotte Chemicals Corp |
Detergent compositions comprising inorganic esters of epoxyhydrocarbon polymers
|
|
US3173876A
(en)
|
1960-05-27 |
1965-03-16 |
John C Zobrist |
Cleaning methods and compositions
|
|
NL271831A
(pl)
|
1960-11-29 |
|
|
|
|
US3493657A
(en)
*
|
1961-03-14 |
1970-02-03 |
Mozes Juda Lewenstein |
Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
|
|
US3332950A
(en)
|
1963-03-23 |
1967-07-25 |
Endo Lab |
14-hydroxydihydronormorphinone derivatives
|
|
US3276586A
(en)
|
1963-08-30 |
1966-10-04 |
Rosaen Filter Co |
Indicating means for fluid filters
|
|
NL6714885A
(pl)
|
1967-11-02 |
1969-05-06 |
|
|
|
US3541006A
(en)
|
1968-07-03 |
1970-11-17 |
Amicon Corp |
Ultrafiltration process
|
|
US3541005A
(en)
|
1969-02-05 |
1970-11-17 |
Amicon Corp |
Continuous ultrafiltration of macromolecular solutions
|
|
US3773955A
(en)
|
1970-08-03 |
1973-11-20 |
Bristol Myers Co |
Analgetic compositions
|
|
US3879555A
(en)
*
|
1970-11-16 |
1975-04-22 |
Bristol Myers Co |
Method of treating drug addicts
|
|
GB1390772A
(en)
|
1971-05-07 |
1975-04-16 |
Endo Lab |
Oral narcotic composition
|
|
FR2183546B1
(pl)
*
|
1972-05-10 |
1975-06-20 |
Servier Lab |
|
|
US3965256A
(en)
*
|
1972-05-16 |
1976-06-22 |
Synergistics |
Slow release pharmaceutical compositions
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US3916889A
(en)
|
1973-09-28 |
1975-11-04 |
Sandoz Ag |
Patient ventilator apparatus
|
|
US3966940A
(en)
*
|
1973-11-09 |
1976-06-29 |
Bristol-Myers Company |
Analgetic compositions
|
|
GB1478759A
(en)
|
1974-11-18 |
1977-07-06 |
Alza Corp |
Process for forming outlet passageways in pills using a laser
|
|
US3966040A
(en)
*
|
1975-03-05 |
1976-06-29 |
Hazelwood John E |
Combined vibratory feeder drive unit, vibratory feeder bowl, and parts separator
|
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4126684A
(en)
|
1976-02-11 |
1978-11-21 |
Ciba-Geigy Corporation |
4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
|
|
US4063064A
(en)
|
1976-02-23 |
1977-12-13 |
Coherent Radiation |
Apparatus for tracking moving workpiece by a laser beam
|
|
US4176186A
(en)
|
1978-07-28 |
1979-11-27 |
Boehringer Ingelheim Gmbh |
Quaternary derivatives of noroxymorphone which relieve intestinal immobility
|
|
US4285987A
(en)
|
1978-10-23 |
1981-08-25 |
Alza Corporation |
Process for manufacturing device with dispersion zone
|
|
US4200098A
(en)
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
|
US4237140A
(en)
|
1979-05-18 |
1980-12-02 |
E. I. Du Pont De Nemours And Company |
Analgesic mixture of nalbuphine and acetaminophen
|
|
US4293539A
(en)
|
1979-09-12 |
1981-10-06 |
Eli Lilly And Company |
Controlled release formulations and method of treatment
|
|
IE49324B1
(en)
|
1979-12-19 |
1985-09-18 |
Euro Celtique Sa |
Controlled release compositions
|
|
US4457933A
(en)
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
|
US4464378A
(en)
|
1981-04-28 |
1984-08-07 |
University Of Kentucky Research Foundation |
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
|
|
US4401672A
(en)
|
1981-10-13 |
1983-08-30 |
Regents Of The University Of Minnesota |
Non-addictive narcotic antitussive preparation
|
|
US4608376A
(en)
|
1981-10-16 |
1986-08-26 |
Carolyn McGinnis |
Opiate agonists and antagonists
|
|
US4987136A
(en)
*
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
|
US4443428A
(en)
*
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
|
US4451470A
(en)
*
|
1982-07-06 |
1984-05-29 |
E. I. Du Pont De Nemours And Company |
Analgesic, antagonist, and/or anorectic 14-fluoromorphinans
|
|
US4803208A
(en)
*
|
1982-09-30 |
1989-02-07 |
Sloan-Kettering Institute For Cancer Research |
Opiate agonists and antagonists
|
|
GB8332556D0
(en)
*
|
1983-12-06 |
1984-01-11 |
Reckitt & Colmann Prod Ltd |
Analgesic compositions
|
|
US5266574A
(en)
*
|
1984-04-09 |
1993-11-30 |
Ian S. Zagon |
Growth regulation and related applications of opioid antagonists
|
|
US4668685A
(en)
*
|
1984-07-05 |
1987-05-26 |
E.I. Du Pont De Nemours And Company |
Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
|
|
DE3434946A1
(de)
*
|
1984-09-22 |
1986-04-03 |
Basf Ag, 6700 Ludwigshafen |
Diarylacetylene, ihre herstellung und verwendung
|
|
US4573995A
(en)
*
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
|
GB8430346D0
(en)
*
|
1984-11-30 |
1985-01-09 |
Reckitt & Colmann Prod Ltd |
Analgesic compositions
|
|
US4806341A
(en)
*
|
1985-02-25 |
1989-02-21 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
|
|
ZA861211B
(en)
|
1985-02-25 |
1987-10-28 |
Lilly Co Eli |
Analgesic composition
|
|
GB8514665D0
(en)
|
1985-06-11 |
1985-07-10 |
Eroceltique Sa |
Oral pharmaceutical composition
|
|
FR2585246A1
(fr)
*
|
1985-07-26 |
1987-01-30 |
Cortial |
Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
|
|
GB8521350D0
(en)
|
1985-08-28 |
1985-10-02 |
Euro Celtique Sa |
Analgesic composition
|
|
US4760069A
(en)
|
1985-09-23 |
1988-07-26 |
Nova Pharmaceutical Corporation |
Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists
|
|
US4889860A
(en)
|
1985-09-23 |
1989-12-26 |
Nova Pharmaceutical Corporation |
Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists
|
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
|
US4730048A
(en)
*
|
1985-12-12 |
1988-03-08 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
|
US4719215A
(en)
*
|
1986-03-07 |
1988-01-12 |
University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
|
US4861781A
(en)
|
1986-03-07 |
1989-08-29 |
The University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
|
US5316759A
(en)
*
|
1986-03-17 |
1994-05-31 |
Robert J. Schaap |
Agonist-antagonist combination to reduce the use of nicotine and other drugs
|
|
GB8613688D0
(en)
*
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB8613689D0
(en)
*
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
EP0249347B1
(en)
*
|
1986-06-10 |
1994-06-29 |
Euroceltique S.A. |
Controlled release dihydrocodeine composition
|
|
US4785000A
(en)
|
1986-06-18 |
1988-11-15 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US4769372A
(en)
|
1986-06-18 |
1988-09-06 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US4970075A
(en)
|
1986-07-18 |
1990-11-13 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
US4861598A
(en)
|
1986-07-18 |
1989-08-29 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
US5356900A
(en)
|
1986-10-07 |
1994-10-18 |
Bernard Bihari |
Method of treating chronic herpes virus infections using an opiate receptor antagonist
|
|
GB8626098D0
(en)
*
|
1986-10-31 |
1986-12-03 |
Euro Celtique Sa |
Controlled release hydromorphone composition
|
|
US4806543A
(en)
*
|
1986-11-25 |
1989-02-21 |
Board Of Trustees Of The Leland Stanford Junior University |
Method and compositions for reducing neurotoxic injury
|
|
GB8628728D0
(en)
|
1986-12-02 |
1987-01-07 |
Euro Celtique Sa |
Spheroids
|
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
|
GB8728294D0
(en)
|
1987-12-03 |
1988-01-06 |
Reckitt & Colmann Prod Ltd |
Treatment compositions
|
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
|
US4873076A
(en)
|
1988-04-29 |
1989-10-10 |
Baker Cummins Pharmaceuticals, Inc. |
Method of safely providing anesthesia or conscious sedation
|
|
GB8813064D0
(en)
*
|
1988-06-02 |
1988-07-06 |
Euro Celtique Sa |
Controlled release dosage forms having defined water content
|
|
US4882335A
(en)
|
1988-06-13 |
1989-11-21 |
Alko Limited |
Method for treating alcohol-drinking response
|
|
EP0352361A1
(en)
|
1988-07-29 |
1990-01-31 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US5236714A
(en)
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
|
CA2002492A1
(en)
|
1988-11-11 |
1990-05-11 |
Sandra T. A. Malkowska |
Pharmaceutical ion exchange resin composition
|
|
US5102887A
(en)
*
|
1989-02-17 |
1992-04-07 |
Arch Development Corporation |
Method for reducing emesis and nausea induced by the administration of an emesis causing agent
|
|
US5096715A
(en)
*
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
|
US5075341A
(en)
|
1989-12-01 |
1991-12-24 |
The Mclean Hospital Corporation |
Treatment for cocaine abuse
|
|
US5086058A
(en)
*
|
1990-06-04 |
1992-02-04 |
Alko Ltd. |
Method for treating alcoholism with nalmefene
|
|
FR2669336B1
(fr)
|
1990-11-20 |
1993-01-22 |
Adir |
Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
HU208633B
(en)
*
|
1991-02-04 |
1993-12-28 |
Alkaloida Vegyeszeti Gyar |
Process for production of analgetic compositions as applicable for blocking of opioid-binding spaces /2-receptors/ causing respiration depression
|
|
US5486362A
(en)
*
|
1991-05-07 |
1996-01-23 |
Dynagen, Inc. |
Controlled, sustained release delivery system for treating drug dependency
|
|
US5149538A
(en)
|
1991-06-14 |
1992-09-22 |
Warner-Lambert Company |
Misuse-resistive transdermal opioid dosage form
|
|
KR100221695B1
(ko)
|
1991-08-12 |
1999-09-15 |
그린 마틴, 브라이언 쥐 테슬리 |
약학적 구상 제형
|
|
GB9117361D0
(en)
|
1991-08-12 |
1991-09-25 |
Euro Celtique Sa |
Oral dosage form
|
|
KR100243956B1
(ko)
|
1991-09-06 |
2000-03-02 |
랄프 알. 팔로 |
트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물
|
|
US5215758A
(en)
*
|
1991-09-11 |
1993-06-01 |
Euroceltique, S.A. |
Controlled release matrix suppository for pharmaceuticals
|
|
US5225440A
(en)
|
1991-09-13 |
1993-07-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase
|
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5958459A
(en)
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5286493A
(en)
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
GB9203689D0
(en)
*
|
1992-02-20 |
1992-04-08 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB9204354D0
(en)
|
1992-02-28 |
1992-04-08 |
Biokine Tech Ltd |
Compounds for medicinal use
|
|
JP3301024B2
(ja)
*
|
1992-06-22 |
2002-07-15 |
ザ・リージェンツ・オブ・ザ・ユニバーシテイ・オブ・カリフォルニア |
グリシンレセプター拮抗物質及びその用途
|
|
US5352680A
(en)
|
1992-07-15 |
1994-10-04 |
Regents Of The University Of Minnesota |
Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
|
|
US5256669A
(en)
|
1992-08-07 |
1993-10-26 |
Aminotek Sciences, Inc. |
Methods and compositions for treating acute or chronic pain and drug addiction
|
|
US5324351A
(en)
|
1992-08-13 |
1994-06-28 |
Euroceltique |
Aqueous dispersions of zein and preparation thereof
|
|
US20010006967A1
(en)
|
1992-09-21 |
2001-07-05 |
Stanley M. Crain |
Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
|
|
US5512578A
(en)
*
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
|
US5633259A
(en)
*
|
1992-09-21 |
1997-05-27 |
United Biomedical, Inc. |
Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction
|
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
US5580876A
(en)
|
1992-09-21 |
1996-12-03 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
US5472943A
(en)
|
1992-09-21 |
1995-12-05 |
Albert Einstein College Of Medicine Of Yeshiva University, |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
|
|
US5869097A
(en)
*
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
|
US5604260A
(en)
*
|
1992-12-11 |
1997-02-18 |
Merck Frosst Canada Inc. |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
|
|
US5321012A
(en)
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
|
US5585348A
(en)
|
1993-02-10 |
1996-12-17 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia
|
|
US5352683A
(en)
|
1993-03-05 |
1994-10-04 |
Virginia Commonwealth University Medical College Of Virginia |
Method for the treatment of chronic pain
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5409944A
(en)
*
|
1993-03-12 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
|
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
|
US5457208A
(en)
|
1993-06-21 |
1995-10-10 |
Regents Of The University Of Minnesota |
Kappa opioid receptor antagonists
|
|
US5436265A
(en)
|
1993-11-12 |
1995-07-25 |
Merck Frosst Canada, Inc. |
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
|
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
|
NZ260883A
(en)
|
1993-07-01 |
1997-06-24 |
Euro Celtique Sa |
Oral sustained-release medicaments containing morphine
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
|
DE4325465B4
(de)
|
1993-07-29 |
2004-03-04 |
Zenz, Michael, Prof. Dr.med. |
Orales pharmazeutisches Präparat für die Schmerztherapie
|
|
GB9319568D0
(en)
*
|
1993-09-22 |
1993-11-10 |
Euro Celtique Sa |
Pharmaceutical compositions and usages
|
|
EP0647448A1
(en)
|
1993-10-07 |
1995-04-12 |
Euroceltique S.A. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
EP0654263B1
(en)
|
1993-11-23 |
2002-01-23 |
Euro-Celtique S.A. |
Method for preparing a sustained release composition
|
|
US6210714B1
(en)
*
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
|
US5834477A
(en)
|
1993-12-08 |
1998-11-10 |
The United States Of America As Represented By The Secretary Of The Army |
Opiate analgesic formulation with improved safety
|
|
US5376662A
(en)
|
1993-12-08 |
1994-12-27 |
Ockert; David M. |
Method of attenuating nerve injury induced pain
|
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
|
US5616601A
(en)
*
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
|
US5521213A
(en)
*
|
1994-08-29 |
1996-05-28 |
Merck Frosst Canada, Inc. |
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
|
|
US5593994A
(en)
*
|
1994-09-29 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Prostaglandin synthase inhibitors
|
|
US5866154A
(en)
*
|
1994-10-07 |
1999-02-02 |
The Dupont Merck Pharmaceutical Company |
Stabilized naloxone formulations
|
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
EP1609477B1
(en)
*
|
1994-12-12 |
2011-11-09 |
Omeros Corporation |
Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
|
|
GB9426102D0
(en)
*
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Pharmacuetical compositions
|
|
US5692500A
(en)
|
1995-01-09 |
1997-12-02 |
Gaston-Johansson; Fannie |
Pain measurement and recording tool and method
|
|
US5552422A
(en)
|
1995-01-11 |
1996-09-03 |
Merck Frosst Canada, Inc. |
Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
|
|
US5578725A
(en)
|
1995-01-30 |
1996-11-26 |
Regents Of The University Of Minnesota |
Delta opioid receptor antagonists
|
|
US20020006964A1
(en)
*
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
|
US5604253A
(en)
*
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5639780A
(en)
*
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5510368A
(en)
*
|
1995-05-22 |
1996-04-23 |
Merck Frosst Canada, Inc. |
N-benzyl-3-indoleacetic acids as antiinflammatory drugs
|
|
DE69632569T2
(de)
|
1995-06-09 |
2005-08-18 |
Euroceltique S.A. |
Formulierungen und verfahren für eine verlängerte lokalanästhesie
|
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
|
GB9517883D0
(en)
*
|
1995-09-01 |
1995-11-01 |
Euro Celtique Sa |
Improved pharmaceutical ion exchange resin composition
|
|
GB9519363D0
(en)
*
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
|
US5811126A
(en)
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
|
AUPN603895A0
(en)
|
1995-10-19 |
1995-11-09 |
University Of Queensland, The |
Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
|
|
US5998434A
(en)
|
1995-12-06 |
1999-12-07 |
Eli Lilly And Company |
Composition for treating pain
|
|
DK0914097T3
(da)
*
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
|
US6103258A
(en)
|
1996-04-12 |
2000-08-15 |
Simon; David Lew |
Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-Methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opioid analgesics
|
|
DE19651551C2
(de)
*
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioidantagonisthaltige galenische Formulierung
|
|
SK282549B6
(sk)
|
1997-02-14 |
2002-10-08 |
G�decke Aktiengesellschaft |
Spôsob stabilizácie naloxonhydrochloridu
|
|
DE29719704U1
(de)
|
1997-02-14 |
1998-01-22 |
Gödecke AG, 10587 Berlin |
Stabile Zubereitungen von Naloxonhydrochlorid
|
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
DE19710008A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
US5780479A
(en)
|
1997-04-04 |
1998-07-14 |
Regents Of The University Of Minnesota |
Use of opioid antagonists to treat impulse-control disorders
|
|
US6207142B1
(en)
*
|
1997-04-14 |
2001-03-27 |
Janssen Pharmaceutica N.V. |
Compositions containing an antifungal and a cationic agent
|
|
EP1009387B1
(en)
|
1997-07-02 |
2006-04-12 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
|
ATE210983T1
(de)
|
1997-11-03 |
2002-01-15 |
Stada Arzneimittel Ag |
Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
|
|
US5972954A
(en)
|
1997-11-03 |
1999-10-26 |
Arch Development Corporation |
Use of methylnaltrexone and related compounds
|
|
CA2314893C
(en)
*
|
1997-12-22 |
2005-09-13 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist combinations
|
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
US6375957B1
(en)
*
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
BR9908953A
(pt)
|
1998-03-27 |
2000-12-05 |
Upjohn Co |
Utilização de cabergolina no tratamento da sìndrome de pernas agitadas (sìndrome de ekbom)
|
|
DE19857766A1
(de)
|
1998-05-28 |
1999-12-02 |
Krewel Meuselbach Gmbh |
Retardiertes Schmerzmittel enthaltend Tilidin
|
|
DE19859636A1
(de)
|
1998-12-23 |
2000-06-29 |
Hexal Ag |
Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
|
|
US6194382B1
(en)
*
|
1999-03-03 |
2001-02-27 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
|
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
|
US6765010B2
(en)
|
1999-05-06 |
2004-07-20 |
Pain Therapeutics, Inc. |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
|
|
US20030178031A1
(en)
|
1999-05-07 |
2003-09-25 |
Du Pen, Inc. |
Method for cancer pain treatment
|
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
DE19938823A1
(de)
|
1999-08-19 |
2001-02-22 |
Boehringer Ingelheim Pharma |
Medikamentöse Behandlung des Restless Leg Syndroms
|
|
US6258042B1
(en)
|
1999-09-17 |
2001-07-10 |
James S. Factor |
Visual analog scale and method of use for the diagnosis and/or treatment of physical pain
|
|
US6716449B2
(en)
*
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
BR0108379A
(pt)
|
2000-02-08 |
2002-11-05 |
Euro Celtique Sa |
Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
|
|
US7223421B2
(en)
*
|
2000-06-30 |
2007-05-29 |
Mcneil-Ppc, Inc. |
Teste masked pharmaceutical particles
|
|
GB0026137D0
(en)
|
2000-10-25 |
2000-12-13 |
Euro Celtique Sa |
Transdermal dosage form
|
|
AR031152A1
(es)
|
2000-10-31 |
2003-09-10 |
Upjohn Co |
Tratamientos nuevos para el sindrome de piernas inquietas
|
|
CA2444053C
(en)
|
2001-04-19 |
2008-06-17 |
Warner-Lambert Company Llc |
Fused bicyclic or tricyclic amino acids
|
|
CA2778114A1
(en)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
|
WO2003004009A1
(en)
|
2001-07-02 |
2003-01-16 |
Geneva Pharmaceuticals, Inc. |
Pharmaceutical composition
|
|
AU2002316738B2
(en)
*
|
2001-07-18 |
2009-01-08 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
KR20040060917A
(ko)
|
2001-08-06 |
2004-07-06 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 남용을 방지하기 위한 조성물 및 방법
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
US7332182B2
(en)
*
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
HUP0401191A3
(en)
*
|
2001-08-06 |
2006-11-28 |
Euro Celtique Sa |
Opioid agonist formulations with releasable and sequestered antagonist and process for their preparation
|
|
BR0212020A
(pt)
|
2001-08-06 |
2005-08-16 |
Euro Celtique Sa |
Formas de dosagem, métodos para impedir o abuso de uma forma de dosagem, métodos para impedir o desvio de uma forma de dosagem, métodos para o tratamento de dor e método de preparação de uma forma de dosagem
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
EP2957281A1
(en)
|
2001-09-21 |
2015-12-23 |
Egalet Ltd. |
Polymer release system
|
|
US20030092759A1
(en)
*
|
2001-09-24 |
2003-05-15 |
Abuzzahab Faruk S. |
Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
|
|
WO2003073937A1
(en)
|
2002-03-06 |
2003-09-12 |
Euro-Celtique S.A. |
Analog scale for measuring pain
|
|
CA2478558C
(en)
|
2002-03-14 |
2012-09-11 |
Euro-Celtique, S.A. |
Naltrexone hydrochloride compositions
|
|
EP1492506B2
(en)
|
2002-04-05 |
2016-06-29 |
Euro-Celtique S.A. |
Matrix for sustained, invariant and independent release of active compounds
|
|
US20030191147A1
(en)
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
|
EP1364649A1
(en)
|
2002-05-23 |
2003-11-26 |
Cilag AG |
Adduct of topiramate and tramadol hydrochioride and uses thereof
|
|
US7399488B2
(en)
*
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
RU2222260C1
(ru)
|
2002-07-08 |
2004-01-27 |
Сибирский государственный медицинский университет |
Способ дифференцированной оценки степени функциональной активности тонкой кишки
|
|
CN100500130C
(zh)
|
2003-01-23 |
2009-06-17 |
株式会社太平洋 |
缓释制剂及其制备方法
|
|
DK2368554T3
(en)
|
2003-04-08 |
2015-01-26 |
Progenics Pharm Inc |
A pharmaceutical composition comprising methylnaltrexone
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
US20050053659A1
(en)
*
|
2003-09-10 |
2005-03-10 |
Pace Gary W. |
Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
|
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
|
US7700626B2
(en)
|
2004-06-04 |
2010-04-20 |
Adolor Corporation |
Compositions containing opioid antagonists
|
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
US20070092576A1
(en)
|
2005-10-20 |
2007-04-26 |
Adolor Corporation |
Compositions containing opioid antagonists
|
|
EP1813276A1
(en)
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
|
EP2042176A1
(en)
|
2007-09-26 |
2009-04-01 |
Euro-Celtique S.A. |
Use of a combination of an opioid agonist and an opioid antagonist for the treatment of Crohn's disease
|
|
CN105456267A
(zh)
|
2008-07-07 |
2016-04-06 |
欧洲凯尔特公司 |
阿片类拮抗剂治疗尿潴留的用途
|
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|